Good news! Looks like Canada is catching up to us on the myeloma therapy front:
MONTREAL, Aug. 17 /CNW Telbec/ – Manitoba last week became the eighth province to approve funding for Revlimid(R) (lenalidomide) in combination with dexamethasone, as second-line therapy for the treatment of patients with multiple myeloma.
Feel good and keep smiling my Canadian friends! Pat